These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

353 related items for PubMed ID: 23215685

  • 1. Targeting adenosine receptors with coumarins: synthesis and binding activities of amide and carbamate derivatives.
    Matos MJ, Gaspar A, Kachler S, Klotz KN, Borges F, Santana L, Uriarte E.
    J Pharm Pharmacol; 2013 Jan; 65(1):30-4. PubMed ID: 23215685
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and adenosine receptors binding affinities of a series of 3-arylcoumarins.
    Matos MJ, Hogger V, Gaspar A, Kachler S, Borges F, Uriarte E, Santana L, Klotz KN.
    J Pharm Pharmacol; 2013 Nov; 65(11):1590-7. PubMed ID: 24118065
    [Abstract] [Full Text] [Related]

  • 3. Chalcone-based derivatives as new scaffolds for hA3 adenosine receptor antagonists.
    Vazquez-Rodriguez S, Matos MJ, Santana L, Uriarte E, Borges F, Kachler S, Klotz KN.
    J Pharm Pharmacol; 2013 May; 65(5):697-703. PubMed ID: 23600387
    [Abstract] [Full Text] [Related]

  • 4. 1,3-dialkyl-8-N-substituted benzyloxycarbonylamino-9-deazaxanthines as potent adenosine receptor ligands: Design, synthesis, structure-affinity and structure-selectivity relationships.
    Fernández F, Caamaño O, Isabel Nieto M, López C, García-Mera X, Stefanachi A, Nicolotti O, Isabel Loza M, Brea J, Esteve C, Segarra V, Vidal B, Carotti A.
    Bioorg Med Chem; 2009 May 15; 17(10):3618-29. PubMed ID: 19398343
    [Abstract] [Full Text] [Related]

  • 5. Selectivity is species-dependent: Characterization of standard agonists and antagonists at human, rat, and mouse adenosine receptors.
    Alnouri MW, Jepards S, Casari A, Schiedel AC, Hinz S, Müller CE.
    Purinergic Signal; 2015 Sep 15; 11(3):389-407. PubMed ID: 26126429
    [Abstract] [Full Text] [Related]

  • 6. New insight into adenosine receptors selectivity derived from a novel series of [5-substituted-4-phenyl-1,3-thiazol-2-yl] benzamides and furamides.
    Inamdar GS, Pandya AN, Thakar HM, Sudarsanam V, Kachler S, Sabbadin D, Moro S, Klotz KN, Vasu KK.
    Eur J Med Chem; 2013 May 15; 63():924-34. PubMed ID: 23685887
    [Abstract] [Full Text] [Related]

  • 7. Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists.
    Baraldi PG, Tabrizi MA, Preti D, Bovero A, Romagnoli R, Fruttarolo F, Zaid NA, Moorman AR, Varani K, Gessi S, Merighi S, Borea PA.
    J Med Chem; 2004 Mar 11; 47(6):1434-47. PubMed ID: 14998332
    [Abstract] [Full Text] [Related]

  • 8. Identification of novel thiazolo[5,4-d]pyrimidine derivatives as human A1 and A2A adenosine receptor antagonists/inverse agonists.
    Varano F, Catarzi D, Falsini M, Vincenzi F, Pasquini S, Varani K, Colotta V.
    Bioorg Med Chem; 2018 Jul 23; 26(12):3688-3695. PubMed ID: 29880250
    [Abstract] [Full Text] [Related]

  • 9. 7-Amino-2-phenylpyrazolo[4,3-d]pyrimidine derivatives: structural investigations at the 5-position to target human A₁ and A(2A) adenosine receptors. Molecular modeling and pharmacological studies.
    Squarcialupi L, Colotta V, Catarzi D, Varano F, Betti M, Varani K, Vincenzi F, Borea PA, Porta N, Ciancetta A, Moro S.
    Eur J Med Chem; 2014 Sep 12; 84():614-27. PubMed ID: 25063944
    [Abstract] [Full Text] [Related]

  • 10. New 2-heterocyclyl-imidazo[2,1-i]purin-5-one derivatives as potent and selective human A3 adenosine receptor antagonists.
    Baraldi PG, Preti D, Zaid AN, Saponaro G, Tabrizi MA, Baraldi S, Romagnoli R, Moorman AR, Varani K, Cosconati S, Di Maro S, Marinelli L, Novellino E, Borea PA.
    J Med Chem; 2011 Jul 28; 54(14):5205-20. PubMed ID: 21675777
    [Abstract] [Full Text] [Related]

  • 11. Derivatives of benzimidazol-2-ylquinoline and benzimidazol-2-ylisoquinoline as selective A1 adenosine receptor antagonists with stimulant activity on human colon motility.
    Cosimelli B, Taliani S, Greco G, Novellino E, Sala A, Severi E, Da Settimo F, La Motta C, Pugliesi I, Antonioli L, Fornai M, Colucci R, Blandizzi C, Daniele S, Trincavelli ML, Martini C.
    ChemMedChem; 2011 Oct 04; 6(10):1909-18. PubMed ID: 21796795
    [Abstract] [Full Text] [Related]

  • 12. Pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4(3H)-ones as selective human A(1) adenosine receptor ligands.
    Giovannoni MP, Vergelli C, Cilibrizzi A, Crocetti L, Biancalani C, Graziano A, Dal Piaz V, Loza MI, Cadavid MI, Díaz JL, Gavaldà A.
    Bioorg Med Chem; 2010 Nov 15; 18(22):7890-9. PubMed ID: 20937560
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of 2-benzylidene-1-tetralone derivatives as antagonists of A1 and A2A adenosine receptors.
    Legoabe LJ, Van der Walt MM, Terre'Blanche G.
    Chem Biol Drug Des; 2018 Jan 15; 91(1):234-244. PubMed ID: 28734058
    [Abstract] [Full Text] [Related]

  • 14. A new series of 2-alkoxy(aralkoxy)-[1,2,4]triazolo[1,5-a]quinazolin-5-ones as adenosine receptor antagonists.
    Al-Salahi R, Geffken D, Koellner M.
    Chem Pharm Bull (Tokyo); 2011 Jan 15; 59(6):730-3. PubMed ID: 21628909
    [Abstract] [Full Text] [Related]

  • 15. Pyrimidine derivatives as potent and selective A3 adenosine receptor antagonists.
    Yaziji V, Rodríguez D, Gutiérrez-de-Terán H, Coelho A, Caamaño O, García-Mera X, Brea J, Loza MI, Cadavid MI, Sotelo E.
    J Med Chem; 2011 Jan 27; 54(2):457-71. PubMed ID: 21186795
    [Abstract] [Full Text] [Related]

  • 16. Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as adenosine receptor antagonists. Influence of the N5 substituent on the affinity at the human A 3 and A 2B adenosine receptor subtypes: a molecular modeling investigation.
    Pastorin G, Da Ros T, Spalluto G, Deflorian F, Moro S, Cacciari B, Baraldi PG, Gessi S, Varani K, Borea PA.
    J Med Chem; 2003 Sep 25; 46(20):4287-96. PubMed ID: 13678407
    [Abstract] [Full Text] [Related]

  • 17. Identifying novel adenosine receptor ligands by simultaneous proteochemometric modeling of rat and human bioactivity data.
    van Westen GJ, van den Hoven OO, van der Pijl R, Mulder-Krieger T, de Vries H, Wegner JK, Ijzerman AP, van Vlijmen HW, Bender A.
    J Med Chem; 2012 Aug 23; 55(16):7010-20. PubMed ID: 22827545
    [Abstract] [Full Text] [Related]

  • 18. The role of 5-arylalkylamino- and 5-piperazino- moieties on the 7-aminopyrazolo[4,3-d]pyrimidine core in affecting adenosine A1 and A2A receptor affinity and selectivity profiles.
    Squarcialupi L, Betti M, Catarzi D, Varano F, Falsini M, Ravani A, Pasquini S, Vincenzi F, Salmaso V, Sturlese M, Varani K, Moro S, Colotta V.
    J Enzyme Inhib Med Chem; 2017 Dec 23; 32(1):248-263. PubMed ID: 28114825
    [Abstract] [Full Text] [Related]

  • 19. 5-Substituted 2-benzylidene-1-tetralone analogues as A1 and/or A2A antagonists for the potential treatment of neurological conditions.
    Janse van Rensburg HD, Terre'Blanche G, van der Walt MM, Legoabe LJ.
    Bioorg Chem; 2017 Oct 23; 74():251-259. PubMed ID: 28881253
    [Abstract] [Full Text] [Related]

  • 20. Novel 1,3-dipropyl-8-(3-benzimidazol-2-yl-methoxy-1-methylpyrazol-5-yl)xanthines as potent and selective A₂B adenosine receptor antagonists.
    Baraldi PG, Baraldi S, Saponaro G, Preti D, Romagnoli R, Piccagli L, Cavalli A, Recanatini M, Moorman AR, Zaid AN, Varani K, Borea PA, Tabrizi MA.
    J Med Chem; 2012 Jan 26; 55(2):797-811. PubMed ID: 22148859
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.